Financial Performance Highlights

Q1 FY27 Consolidated Results (₹ in Crores)

  • Total Revenue: ₹1,785.2 crore, up 38.5% YoY from ₹1,289.2 crore in Q1 FY26
  • EBITDA: ₹252.5 crore (record quarterly high), up 86.9% YoY from ₹135.1 crore in Q1 FY26
  • EBITDA Margin: 14.1% vs 10.5% in Q1 FY26
  • PAT: ₹165.9 crore, up 108.7% YoY from ₹79.5 crore in Q1 FY26
  • PAT Margin: 9.3% vs 6.2% in Q1 FY26

Comparative Performance

Compared to Q1 FY25 (₹1,315.0 crore revenue):

  • Revenue growth: 35.8%
  • EBITDA growth: 107.1% (from ₹121.9 crore)
  • PAT growth: 165.8% (from ₹62.4 crore)

Operational Metrics

  • EBITDA/MT: ~₹35,458/MT vs. ~₹20,009/MT YoY, reflecting significant improvement in profitability
  • Consolidated volumes: Mid-single digits YoY growth

Regional Performance

  • India Region: Returned to double-digit volume growth YoY
  • AMET Region: Low-single digit decline YoY due to geopolitical developments in West Asia, but showed strong sequential recovery during the quarter
  • ROW Region: Mid-single digit growth YoY

Business Segment Performance

Volume Growth by Category

  • Performance Surfactant: Mid-single digit growth YoY
  • Specialty Care: Mid-single digit growth YoY
  • Overall: Mid-single digit volume growth YoY

Revenue by Category (₹ in Crores)

  • Performance Surfactant: ₹1,178.7 crore
  • Specialty Care: ₹603.2 crore

Management Commentary

Mr. K. Natarajan, Managing Director, commented on the strategic foundations that enabled strong performance despite challenging external environment:

  • Ability to anticipate risks and manage volatility
  • Disciplined commercial decisions
  • Leveraged diversified product portfolio
  • Exceptional efforts across business development, commercial excellence, procurement, global logistics, manufacturing and operations
  • Recovery in customer demand and strong momentum in Specialty Care
  • Confidence in delivering sustainable long-term growth through disciplined execution and customer-centric approach

Operational Context

Company leveraged its diversified product portfolio, agile supply chain, strong vendor relationships, and operational excellence to navigate:

  • Sharp feedstock price fluctuations
  • Supply-chain disruptions linked to developments in West Asia
  • Recovery in demand from Tier-1 customers
  • Higher contribution within Specialty Care strengthening overall mix and profitability
  • Disciplined pricing actions

Company Background

Galaxy Surfactants Limited is a leading manufacturer of performance surfactants and specialty care products with over 215+ product grades used in Home and Personal Care industry. Manufacturing facilities located in India (5), Egypt (1) and USA (1). Key customers include Unilever, Reckitt Benckiser, P&G, L'OREAL, Himalaya, Colgate Palmolive, and CavinKare.